Anzeige
Mehr »
Dienstag, 01.07.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40L5C | ISIN: US30205M3097 | Ticker-Symbol: 2H0
Lang & Schwarz
01.07.25 | 07:00
6,625 Euro
-100,00 % -6,625
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
EXICURE INC Chart 1 Jahr
5-Tage-Chart
EXICURE INC 5-Tage-Chart
RealtimeGeldBriefZeit
6,6006,65007:00

Aktuelle News zur EXICURE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoProgress Software, Exicure And 3 Stocks To Watch Heading Into Monday7
FrEXICURE, INC. - 10-Q, Quarterly Report1
EXICURE Aktie jetzt für 0€ handeln
FrEXICURE, INC. - 8-K, Current Report1
10.06.EXICURE, INC. - 8-K, Current Report1
28.05.EXICURE, INC. - 8-K, Current Report1
28.05.Exicure receives Nasdaq non-compliance notice for late quarterly filing1
28.05.Exicure faces Nasdaq non-compliance notice1
06.05.EXICURE, INC. - 8-K, Current Report3
14.04.EXICURE, INC. - 8-K, Current Report1
18.03.EXICURE, INC. - 10-K, Annual Report1
18.03.EXICURE, INC. - 8-K, Current Report1
13.03.Pre-market Movers: Y-mAbs Therapeutics, Aveanna Healthcare, UiPath, Exicure, CareCloud629SANTA CLARA (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 08.55 A.M. ET).In the Green Aveanna Healthcare Holdings Inc. (AVAH) is up...
► Artikel lesen
05.03.EXICURE, INC. - 8-K, Current Report-
21.02.EXICURE, INC. - 8-K, Current Report-
23.01.Exicure, back from brink and under new management, buys GPCR's US unit and clinical-stage drug2
23.01.Exicure Buys GPCR USA From GPCR Therapeutics, Signs L&C Deal; Stock Climbs1
22.01.EXICURE, INC. - 8-K, Current Report-
06.01.EXICURE, INC. - 8-K, Current Report1
27.12.24Exicure, Inc. Partners with GPCR Therapeutics to Fuel New Growth in Biotech210CHICAGO--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR, "Exicure", "the Company"), has announced the signing of a Memorandum of Understanding (MOU) with GPCR Therapeutics, Inc. ("GPCR Therapeutics")...
► Artikel lesen
20.12.24Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes302CHICAGO--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR, "the Company", "Exicure"), today announced that in connection with the change of control transaction approved by the stockholders at the Special...
► Artikel lesen
Weiter >>
28 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1